2m 2m 2m 2m 2m 2m 2m
GEOVAX LABS (GOVX)
NASDAQ
$1.95-$0.16 (-7.38%)
Price as of Jun 03, 2026 6:57 PM EDT- $10.7MMarket Cap
- -92.00%1-Year Change
- BiotechnologyIndustry
GEOVAX LABS (GOVX)
$1.95-$0.16 (-7.38%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5M -37.06% | 4.0M N/A | 0 -100.00% | 81,526 -78.85% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.5M -37.06% | 4.0M N/A | 0 -100.00% | 81,526 -78.85% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -18.1M -23.58% | -23.7M +14.44% | -20.7M +127.11% | -9.1M -41.34% | |
Depreciation and Amortization Expense | 68,756 -27.90% | 95,368 +28.58% | 74,169 +31.78% | 56,284 +46.11% | |
Total Operating Expenses | 24.1M -17.08% | 29.1M +8.81% | 26.7M +89.53% | 14.1M -26.25% | |
Operating Profit | -21.6M -13.94% | -25.1M -5.98% | -26.7M +90.63% | -14.0M -25.16% | |
Interest Income | 174,276 +0.53% | 173,359 -77.67% | 776,177 +10,333.89% | 7,439 +57.07% | |
Interest Expense | N/A N/A | -21,375 N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 174,276 +14.67% | 151,984 -80.42% | 776,177 +10,333.89% | 7,439 +115.62% | |
Total Nonoperating Income and Expense | 174,276 +14.67% | 151,984 N/A | N/A N/A | 7,439 -95.76% | |
Income before Taxes | -21.6M -13.94% | -25.1M -5.98% | -26.7M +90.63% | -14.0M -25.16% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -21.5M -14.11% | -25.0M -3.75% | -26.0M +85.20% | -14.0M -24.50% | |
Net Income from Continuing Operations Applicable to Common | -21.5M -14.11% | -25.0M -3.75% | -26.0M +85.20% | -14.0M -24.50% | |
Basic EPS and Net Income | -22.40 +364.73% | -4.82 -66.27% | -14.29 +1,621.69% | -0.83 -72.70% | |
Diluted EPS and Net Income | -22.40 +364.73% | -4.82 -66.27% | -14.29 +1,621.69% | -0.83 -72.70% | |
Basic Weighted Average Shares | 958,443 -81.52% | 5.2M +185.43% | 1.8M -89.29% | 17.0M +178.25% | |
Diluted Weighted Average Shares | 958,443 -81.52% | 5.2M +185.43% | 1.8M -89.29% | 17.0M +178.25% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.1M -43.97% | 5.5M -14.66% | 6.5M -76.63% | 27.6M +141.71% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.1M -43.97% | 5.5M -14.66% | 6.5M -76.63% | 27.6M +141.71% | |
Total Current Assets | 5.3M -33.02% | 7.9M +0.62% | 7.9M -72.75% | 28.9M +148.85% | |
Accumulated Depreciation | 403,607 -46.97% | 761,042 +11.81% | 680,674 +12.23% | 606,505 +10.23% | |
Property and Plant and Equipment and Net | 108,830 -27.43% | 149,974 -28.48% | 209,689 -10.74% | 234,912 +49.68% | |
Total Long-Term Assets | 86,947 +22.44% | 71,010 -94.02% | 1.2M -45.37% | 2.2M +1,285.44% | |
Total Assets | 6.3M -22.24% | 8.2M -12.14% | 9.3M -70.39% | 31.3M +165.73% | |
Income Taxes Payable | 882,816 -29.80% | 1.3M +75.41% | 716,931 -76.10% | 3.0M -44.21% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.9M -37.67% | 3.1M -11.72% | 3.5M -25.86% | 4.7M -12.65% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 580,035 N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Liabilities | 2.5M -19.01% | 3.1M -11.72% | 3.5M -25.86% | 4.7M -36.14% | |
Retained Earnings | -150.8M +16.59% | -129.4M +23.95% | -104.4M +33.12% | -78.4M +21.78% | |
Total Stockholders Equity | 3.8M -24.23% | 5.0M -12.40% | 5.8M -78.33% | 26.6M +509.85% | |
Total Shares Outstanding | 1.7M -83.56% | 10.5M +432.93% | 2.0M -92.49% | 26.3M +312.67% | |
Cash Flow | |||||
Cash from Operating Activities | -21.5M -12.97% | -24.7M -1.98% | -25.2M +32.28% | -19.0M +69.97% | |
Capital Expenditures | 27,612 +33.69% | 20,653 -57.80% | 48,946 -63.54% | 134,258 +181.36% | |
Cash from Investing Activities | -27,612 +33.69% | -20,653 -57.80% | -48,946 -63.54% | -134,258 +181.36% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.1M -19.66% | 23.8M +484.64% | 4.1M -88.51% | 35.4M +176.54% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -869.34% +36.73% | -635.83% N/A | N/A N/A | -17,207.47% +253.87% | |
Return on Assets | -296.11% +3.31% | -286.62% +124.25% | -127.82% +96.66% | -65.00% -61.17% | |
Return on Equity | -483.79% +4.64% | -462.31% +188.10% | -160.47% +77.18% | -90.57% -66.03% | |
Revenue Growth | -37.06% N/A | N/A N/A | -100.00% +26.82% | -78.85% -0.01% | |
Current Ratio | 2.74 +7.46% | 2.55 +13.98% | 2.24 -63.24% | 6.10 +184.88% | |
Cash Ratio | 1.59 -10.09% | 1.77 -3.33% | 1.83 -68.48% | 5.82 +176.71% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow